Can routine oral care with antiseptics prevent ventilator-associated pneumonia in patients receiving mechanical ventilation? An update meta-analysis from 17 randomized controlled trials.

BACKGROUND Whether oral antiseptics could reduce the risk of ventilator associated pneumonia (VAP) in patients receiving mechanical ventilation remains controversial. We performed a meta-analysis to assess the effect of oral care with antiseptics on the prevalence of ventilator associated pneumonia in adult critically ill patients. METHODS A comprehensive search of PubMed, Embase and Web of Science were performed to identity relevant studies. Eligible studies were randomized controlled trials of mechanically ventilated adult patients receiving oral care with antiseptics. The quality of included studies was assessed by the Jadad score. Relative risks (RRs), weighted mean differences (WMDs), and 95% confidence intervals (CIs) were calculated and pooled using a fixed-effects model or random-effects model. Heterogeneity among the studies was assessed with I (2) test. RESULTS 17 studies with a total number of 4249 met the inclusion criteria. Of the 17 studies, 14 assessed the effect of chlorhexidine, and 3 investigated the effect of povidone-iodine. Overall, oral care with antiseptics significantly reduced the prevalence of VAP (RR=0.72, 95% CI: 0.57, 0.92; P=0.008). The use of chlorhexidine was shown to be effective (RR=0.73, 95% CI: 0.57, 0.93; P=0.012), whereas this effect was not observed in povidone-iodine (RR=0.51, 95% CI: 0.09, 2.82; P=0.438). Subgroup analyses showed that oral antiseptics were most marked in cardiac surgery patients (RR=0.54, 95% CI: 0.39, 0.74; P=0.00). Patients with oral antiseptics did not have a reduction in intensive care unit (ICU) mortality (RR=1.11, 95% CI: 0.95, 1.29; P=0.201), length of ICU stay (WMD=-0.10 days, 95% CI: -0.25, 0.05; P=0.188), or duration of mechanical ventilation (WMD=-0.05 days, 95% CI: -0.14, 0.04; P=0.260). CONCLUSION Oral care with antiseptics significantly reduced the prevalence of VAP. Chlorhexidine application prevented the occurrence of VAP in mechanically ventilated patients but povidone-iodine did not. Further large-scale, well-designed randomized controlled trials are needed to identify the findings and determine the effect of povidone-iodine application.

[1]  M. Meade,et al.  Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[2]  N. Safdar,et al.  Topical chlorhexidine for prevention of ventilator-associated pneumonia: A meta-analysis* , 2007, Critical care medicine.

[3]  J. Rello,et al.  A randomized trial of dental brushing for preventing ventilator-associated pneumonia. , 2009, Chest.

[4]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[5]  V. Thamlikitkul,et al.  Randomized Controlled Trial and Meta-analysis of Oral Decontamination with 2% Chlorhexidine Solution for the Prevention of Ventilator-Associated Pneumonia , 2008, Infection Control & Hospital Epidemiology.

[6]  C. di Pompéo,et al.  Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: A double-blind placebo-controlled multicenter study* , 2005, Critical care medicine.

[7]  B. D. de Mol,et al.  Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. , 2006, JAMA.

[8]  A J DeRiso,et al.  Chlorhexidine Gluconate 0.12% Oral Rinse Reduces the Incidence of Total Nosocomial Respiratory Infection and Nonprophylactic Systemic Antibiotic Use in Patients Undergoing Heart Surgery , 1996, Chest.

[9]  T. Boulain,et al.  Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control study , 2001, Critical care medicine.

[10]  M. Bonten,et al.  Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. , 2006, American journal of respiratory and critical care medicine.

[11]  E. Chan.  Oral decontamination for ventilator-associated pneumonia prevention. , 2009, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[12]  C. Chopin,et al.  Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients , 2000, Intensive Care Medicine.

[13]  A. Kurokawa,et al.  Chlorhexidine gluconate ingestion resulting in fatal respiratory distress syndrome. , 2002, Veterinary and human toxicology.

[14]  Mauricio Valencia,et al.  Ventilator-associated pneumonia , 2009, Current opinion in critical care.

[15]  M. Kollef.  Prevention of nosocomial pneumonia in the intensive care unit: beyond the use of bundles. , 2011, Surgical infections.

[16]  M. Tang,et al.  Acute pulmonary toxic effects of chlorhexidine (CHX) following an intratracheal instillation in rats , 2011, Human & experimental toxicology.

[17]  Larry J. Anderson,et al.  Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, Respiratory care.

[18]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[19]  J. Nicolás,et al.  Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. , 1999, American journal of respiratory and critical care medicine.

[20]  O. Basoglu,et al.  Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: a randomized clinical trial. , 2012, Journal of periodontal research.

[21]  A. Amin.  Clinical and economic consequences of ventilator-associated pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Jordi Rello,et al.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.

[23]  C. Bridges,et al.  Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[24]  A. Basile-Filho,et al.  Effectiveness of Oral Rinse with Chlorhexidine in Preventing Nosocomial Respiratory Tract Infections among Intensive Care Unit Patients , 2009, Infection Control & Hospital Epidemiology.

[25]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[26]  Maria de Fátima Meinberg Cheade,et al.  Uso de clorexidina 2% gel e escovação mecânica na higiene bucal de pacientes sob ventilação mecânica: efeitos na pneumonia associada a ventilador , 2012 .

[27]  V. M. Kothari,et al.  Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. , 2009, Chest.

[28]  Dirk Vogelaers,et al.  Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. , 2011, The Lancet. Infectious diseases.

[29]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[30]  M. J. Grap,et al.  Oral health and care in the intensive care unit: state of the science. , 2004, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[31]  K. Loftin,et al.  Effects of daily oral care with 0.12% chlorhexidine gluconate and a standard oral care protocol on the development of nosocomial pneumonia in intubated patients: a pilot study. , 2006, Journal of dental hygiene : JDH.

[32]  S. Blot,et al.  Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[34]  R. Ataee.  To: The use of 2% chlorhexidine gel and toothbrushing for oral hygiene of patients receiving mechanical ventilation: effects on ventilator-associated pneumonia , 2014, Revista Brasileira de terapia intensiva.

[35]  B. Laviolle,et al.  Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma* , 2006, Critical care medicine.

[36]  J. Rello,et al.  New issues and controversies in the prevention of ventilator-associated pneumonia. , 2010, American journal of respiratory and critical care medicine.

[37]  Jordi Rello,et al.  A European care bundle for prevention of ventilator-associated pneumonia , 2010, Intensive Care Medicine.

[38]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[39]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[40]  J. Marshall,et al.  Determinants of outcome in patients with a clinical suspicion of ventilator-associated pneumonia. , 2008, Journal of critical care.

[41]  Jihnhee Yu,et al.  A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients , 2009, Critical care.

[42]  M. Larocco,et al.  Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. , 2002, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[43]  K. Ward,et al.  Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. , 2004, Heart & lung : the journal of critical care.

[44]  R. Wunderink,et al.  Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. , 1998, American journal of respiratory and critical care medicine.

[45]  A. E. El Solh,et al.  Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis , 2006, Critical care.

[46]  K. Asehnoune,et al.  Effect of Oropharyngeal Povidone-Iodine Preventive Oral Care on Ventilator-Associated Pneumonia in Severely Brain-Injured or Cerebral Hemorrhage Patients: A Multicenter, Randomized Controlled Trial* , 2014, Critical care medicine.

[47]  P. Davidson,et al.  Effects of three approaches to standardized oral hygiene to reduce bacterial colonization and ventilator associated pneumonia in mechanically ventilated patients: a randomised control trial. , 2011, International journal of nursing studies.

[48]  D. Maki,et al.  The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. , 2005, Respiratory care.

[49]  J. Rello,et al.  Evidence on measures for the prevention of ventilator-associated pneumonia , 2007, European Respiratory Journal.

[50]  K. Orito,et al.  Effects of Single Intratracheal Exposure to Chlorhexidine Gluconate on the Rat Lung , 2006, Drug and chemical toxicology.